

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 5.63964137 |
| 2 | actin-myosin filament sliding (GO:0033275) | 5.63964137 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.91629430 |
| 4 | actin-mediated cell contraction (GO:0070252) | 4.71080602 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.55657176 |
| 6 | myofibril assembly (GO:0030239) | 4.45671230 |
| 7 | cardiac myofibril assembly (GO:0055003) | 4.42074109 |
| 8 | sarcomere organization (GO:0045214) | 4.16854025 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.94673895 |
| 10 | cardiac muscle contraction (GO:0060048) | 3.93438717 |
| 11 | striated muscle contraction (GO:0006941) | 3.81385640 |
| 12 | actin filament-based movement (GO:0030048) | 3.71060407 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 3.69522708 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.63200464 |
| 15 | skeletal muscle contraction (GO:0003009) | 3.59765289 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 3.58670071 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 3.58399750 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.54637529 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.53509925 |
| 20 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.50298415 |
| 21 | sodium ion export (GO:0071436) | 3.47860424 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.46034591 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 3.44860575 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.43654762 |
| 25 | striated muscle hypertrophy (GO:0014897) | 3.42397718 |
| 26 | actomyosin structure organization (GO:0031032) | 3.36966824 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.36679989 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.34711910 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 3.33328173 |
| 30 | regulation of the force of heart contraction (GO:0002026) | 3.20361548 |
| 31 | cell communication by electrical coupling (GO:0010644) | 3.18206953 |
| 32 | muscle contraction (GO:0006936) | 3.16955095 |
| 33 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.14932274 |
| 34 | cardiac muscle adaptation (GO:0014887) | 3.13864519 |
| 35 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.13864519 |
| 36 | muscle hypertrophy in response to stress (GO:0003299) | 3.13864519 |
| 37 | positive regulation of myotube differentiation (GO:0010831) | 3.13723321 |
| 38 | response to inactivity (GO:0014854) | 3.09719894 |
| 39 | muscle hypertrophy (GO:0014896) | 3.05715331 |
| 40 | cellular response to epinephrine stimulus (GO:0071872) | 3.01099154 |
| 41 | creatine metabolic process (GO:0006600) | 2.97201798 |
| 42 | plasma membrane repair (GO:0001778) | 2.96651772 |
| 43 | response to muscle activity (GO:0014850) | 2.96590059 |
| 44 | muscle system process (GO:0003012) | 2.91146497 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 2.90239392 |
| 46 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.88176201 |
| 47 | striated muscle adaptation (GO:0014888) | 2.86604011 |
| 48 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.80164936 |
| 49 | negative regulation of inclusion body assembly (GO:0090084) | 2.78932010 |
| 50 | skeletal muscle fiber development (GO:0048741) | 2.77564759 |
| 51 | regulation of striated muscle contraction (GO:0006942) | 2.75302761 |
| 52 | response to epinephrine (GO:0071871) | 2.67741281 |
| 53 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.65674922 |
| 54 | cell migration involved in heart development (GO:0060973) | 2.64216712 |
| 55 | activation of protein kinase A activity (GO:0034199) | 2.61171928 |
| 56 | muscle tissue morphogenesis (GO:0060415) | 2.61165939 |
| 57 | focal adhesion assembly (GO:0048041) | 2.60912981 |
| 58 | cell-substrate adherens junction assembly (GO:0007045) | 2.60912981 |
| 59 | metanephric mesenchyme development (GO:0072075) | 2.58703746 |
| 60 | barbed-end actin filament capping (GO:0051016) | 2.57895052 |
| 61 | adherens junction assembly (GO:0034333) | 2.56729727 |
| 62 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.55581589 |
| 63 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.55581589 |
| 64 | kidney mesenchyme development (GO:0072074) | 2.55311673 |
| 65 | stress fiber assembly (GO:0043149) | 2.54268917 |
| 66 | cell communication involved in cardiac conduction (GO:0086065) | 2.53740299 |
| 67 | skeletal muscle adaptation (GO:0043501) | 2.48963950 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 2.48452714 |
| 69 | extracellular matrix assembly (GO:0085029) | 2.47397972 |
| 70 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.47046268 |
| 71 | glutamate secretion (GO:0014047) | 2.45915704 |
| 72 | sperm capacitation (GO:0048240) | 2.45234647 |
| 73 | myelination in peripheral nervous system (GO:0022011) | 2.44241004 |
| 74 | peripheral nervous system axon ensheathment (GO:0032292) | 2.44241004 |
| 75 | cGMP-mediated signaling (GO:0019934) | 2.43549548 |
| 76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.43050173 |
| 77 | protein heterotrimerization (GO:0070208) | 2.42587615 |
| 78 | myotube cell development (GO:0014904) | 2.42492803 |
| 79 | muscle adaptation (GO:0043500) | 2.42455832 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 2.41202633 |
| 81 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.39676779 |
| 82 | myoblast fusion (GO:0007520) | 2.38593183 |
| 83 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.38442068 |
| 84 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.37774459 |
| 85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.37768947 |
| 86 | cell-substrate junction assembly (GO:0007044) | 2.37393277 |
| 87 | neuronal ion channel clustering (GO:0045161) | 2.37176504 |
| 88 | muscle organ development (GO:0007517) | 2.36324653 |
| 89 | cellular response to monoamine stimulus (GO:0071868) | 2.34491915 |
| 90 | cellular response to catecholamine stimulus (GO:0071870) | 2.34491915 |
| 91 | protein targeting to plasma membrane (GO:0072661) | 2.34145226 |
| 92 | skeletal muscle tissue development (GO:0007519) | 2.33581231 |
| 93 | locomotory exploration behavior (GO:0035641) | 2.33515865 |
| 94 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.33248711 |
| 95 | muscle structure development (GO:0061061) | 2.30911404 |
| 96 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.29353193 |
| 97 | relaxation of muscle (GO:0090075) | 2.29275667 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 2.29248713 |
| 99 | synaptic vesicle maturation (GO:0016188) | 2.28791573 |
| 100 | NADH metabolic process (GO:0006734) | 2.27923115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.06752574 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.94367995 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.94304882 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.65046065 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.38905362 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19771703 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08399346 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07311028 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94840830 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94840830 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92506745 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.89800575 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87893749 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85682779 |
| 15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81072285 |
| 16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81072285 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80857228 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.79383644 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79278229 |
| 20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79113783 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72115586 |
| 22 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.71648055 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70340890 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70044530 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69651166 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.69436882 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.67958708 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63315409 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.62447704 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58843272 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58214543 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57073804 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54480308 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53511842 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.52479292 |
| 36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50921108 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50894580 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49908243 |
| 39 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.49817007 |
| 40 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49742526 |
| 41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.46213301 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44140384 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40876029 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38969728 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38604545 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37055740 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33632773 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32609872 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32386846 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31675963 |
| 51 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30266399 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28583175 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28090713 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26591140 |
| 55 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.25770716 |
| 56 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.25319773 |
| 57 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23160215 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19466827 |
| 59 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17499533 |
| 60 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17392573 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17087136 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14286924 |
| 63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13089977 |
| 64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12366407 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11818196 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11348231 |
| 67 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10760682 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09972641 |
| 69 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07012328 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06222004 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01334197 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01141239 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00059252 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99999485 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99656749 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99176619 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98553617 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97941399 |
| 79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97442982 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95701805 |
| 81 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95235059 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95217224 |
| 83 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95157836 |
| 84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94550008 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 0.94316528 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93439210 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93317601 |
| 88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92846885 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91865152 |
| 90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91059495 |
| 91 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87934516 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87560455 |
| 93 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87500614 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86743557 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85596905 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84248265 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83953150 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83235913 |
| 99 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82802426 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82577473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 5.05902375 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.90471663 |
| 3 | MP0000749_muscle_degeneration | 3.67779239 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.20164141 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.07645607 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.04685905 |
| 7 | MP0003646_muscle_fatigue | 2.95745675 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.78031982 |
| 9 | MP0001958_emphysema | 2.50226731 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.43262736 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.41325443 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.38848805 |
| 13 | MP0000747_muscle_weakness | 2.38260415 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.36385413 |
| 15 | MP0003279_aneurysm | 2.34225677 |
| 16 | MP0005275_abnormal_skin_tensile | 2.26336767 |
| 17 | MP0005670_abnormal_white_adipose | 2.24370291 |
| 18 | MP0004130_abnormal_muscle_cell | 2.23058377 |
| 19 | MP0004510_myositis | 2.11373215 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.01451083 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.00103077 |
| 22 | MP0002269_muscular_atrophy | 1.99396493 |
| 23 | MP0005330_cardiomyopathy | 1.95323237 |
| 24 | MP0005451_abnormal_body_composition | 1.87995343 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.86125158 |
| 26 | MP0005369_muscle_phenotype | 1.85599698 |
| 27 | MP0004270_analgesia | 1.85560565 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.82915293 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.77902162 |
| 30 | MP0004233_abnormal_muscle_weight | 1.77159535 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.70925624 |
| 32 | MP0000733_abnormal_muscle_development | 1.68907454 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.68228349 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.62007322 |
| 35 | MP0006138_congestive_heart_failure | 1.61615671 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.57586258 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.53902595 |
| 38 | MP0003329_amyloid_beta_deposits | 1.47536858 |
| 39 | MP0004272_abnormal_basement_membrane | 1.46931028 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.39019503 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.36691936 |
| 42 | MP0004484_altered_response_of | 1.35320442 |
| 43 | MP0003879_abnormal_hair_cell | 1.35014858 |
| 44 | MP0010630_abnormal_cardiac_muscle | 1.32729682 |
| 45 | MP0005410_abnormal_fertilization | 1.32148320 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.31421418 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.29714235 |
| 48 | MP0008569_lethality_at_weaning | 1.26524573 |
| 49 | MP0003137_abnormal_impulse_conducting | 1.26100368 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.25109315 |
| 51 | MP0003091_abnormal_cell_migration | 1.22896069 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.22683125 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.20535841 |
| 54 | MP0003690_abnormal_glial_cell | 1.19626402 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.19284544 |
| 56 | MP0003828_pulmonary_edema | 1.16128603 |
| 57 | MP0005385_cardiovascular_system_phenoty | 1.12998667 |
| 58 | MP0001544_abnormal_cardiovascular_syste | 1.12998667 |
| 59 | MP0003635_abnormal_synaptic_transmissio | 1.12094637 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.11550948 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.08692869 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.07807586 |
| 63 | MP0005595_abnormal_vascular_smooth | 1.07395316 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.06310639 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.05301521 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 0.99167802 |
| 67 | MP0002971_abnormal_brown_adipose | 0.98893028 |
| 68 | MP0002896_abnormal_bone_mineralization | 0.98145461 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.97982672 |
| 70 | MP0004858_abnormal_nervous_system | 0.97978813 |
| 71 | MP0005257_abnormal_intraocular_pressure | 0.97782648 |
| 72 | MP0000920_abnormal_myelination | 0.97730373 |
| 73 | MP0005409_darkened_coat_color | 0.95494960 |
| 74 | MP0005165_increased_susceptibility_to | 0.93961183 |
| 75 | MP0002249_abnormal_larynx_morphology | 0.92760083 |
| 76 | MP0004085_abnormal_heartbeat | 0.92426035 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.91877396 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 0.86440440 |
| 79 | MP0003045_fibrosis | 0.86022711 |
| 80 | MP0002064_seizures | 0.84677834 |
| 81 | MP0003634_abnormal_glial_cell | 0.84632863 |
| 82 | MP0001486_abnormal_startle_reflex | 0.82741491 |
| 83 | MP0003075_altered_response_to | 0.79846942 |
| 84 | MP0005508_abnormal_skeleton_morphology | 0.78902476 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.77518863 |
| 86 | MP0002063_abnormal_learning/memory/cond | 0.76978629 |
| 87 | MP0009840_abnormal_foam_cell | 0.75313403 |
| 88 | MP0001849_ear_inflammation | 0.72135859 |
| 89 | MP0001542_abnormal_bone_strength | 0.71834390 |
| 90 | MP0005171_absent_coat_pigmentation | 0.71437587 |
| 91 | MP0000604_amyloidosis | 0.69095584 |
| 92 | MP0005023_abnormal_wound_healing | 0.68826454 |
| 93 | MP0002060_abnormal_skin_morphology | 0.67283118 |
| 94 | MP0000343_altered_response_to | 0.66286167 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.64431575 |
| 96 | MP0003633_abnormal_nervous_system | 0.64322305 |
| 97 | MP0002272_abnormal_nervous_system | 0.63305850 |
| 98 | MP0005166_decreased_susceptibility_to | 0.60679539 |
| 99 | MP0008874_decreased_physiological_sensi | 0.60622841 |
| 100 | MP0002128_abnormal_blood_circulation | 0.60435964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 6.55161912 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.01748768 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.96793758 |
| 4 | Nemaline bodies (HP:0003798) | 5.94856792 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.02350309 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.39985516 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.36330570 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 4.23370287 |
| 9 | Increased variability in muscle fiber diameter (HP:0003557) | 4.19758764 |
| 10 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.13774814 |
| 11 | Increased connective tissue (HP:0009025) | 4.05858255 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.88044546 |
| 13 | Round ear (HP:0100830) | 3.86987355 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 3.77319983 |
| 15 | EMG: myopathic abnormalities (HP:0003458) | 3.72026183 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.66600613 |
| 17 | Sudden death (HP:0001699) | 3.65190253 |
| 18 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.53213250 |
| 19 | Bundle branch block (HP:0011710) | 3.48924447 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.44056208 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.36131067 |
| 22 | Spinal rigidity (HP:0003306) | 3.32653554 |
| 23 | Distal arthrogryposis (HP:0005684) | 3.31235104 |
| 24 | Premature rupture of membranes (HP:0001788) | 3.27613382 |
| 25 | Myopathic facies (HP:0002058) | 3.21684437 |
| 26 | Neck muscle weakness (HP:0000467) | 3.17428067 |
| 27 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.16474741 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 3.13270351 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 3.06660572 |
| 30 | Ventricular tachycardia (HP:0004756) | 3.04535647 |
| 31 | Difficulty running (HP:0009046) | 3.02887041 |
| 32 | Aortic aneurysm (HP:0004942) | 2.92546279 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 2.92157272 |
| 34 | Subaortic stenosis (HP:0001682) | 2.91399990 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.91399990 |
| 36 | Slender build (HP:0001533) | 2.85822520 |
| 37 | Rhabdomyolysis (HP:0003201) | 2.74837208 |
| 38 | Myoglobinuria (HP:0002913) | 2.72092455 |
| 39 | Lower limb amyotrophy (HP:0007210) | 2.63144011 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.58164361 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 2.52130929 |
| 42 | Frequent falls (HP:0002359) | 2.51125491 |
| 43 | Obstructive sleep apnea (HP:0002870) | 2.48696770 |
| 44 | Lipoatrophy (HP:0100578) | 2.47602059 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.47058426 |
| 46 | Myotonia (HP:0002486) | 2.43346270 |
| 47 | Heart block (HP:0012722) | 2.43327736 |
| 48 | Calcaneovalgus deformity (HP:0001848) | 2.40224134 |
| 49 | Atrial fibrillation (HP:0005110) | 2.39746254 |
| 50 | Scapular winging (HP:0003691) | 2.33158649 |
| 51 | Shallow orbits (HP:0000586) | 2.28456723 |
| 52 | Muscle stiffness (HP:0003552) | 2.28274408 |
| 53 | Aortic dissection (HP:0002647) | 2.28243270 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.27883723 |
| 55 | Vascular tortuosity (HP:0004948) | 2.27814383 |
| 56 | Foot dorsiflexor weakness (HP:0009027) | 2.22108053 |
| 57 | Primary atrial arrhythmia (HP:0001692) | 2.19078783 |
| 58 | Dilated cardiomyopathy (HP:0001644) | 2.18218621 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.18023286 |
| 60 | Deformed tarsal bones (HP:0008119) | 2.16758818 |
| 61 | Ankle contracture (HP:0006466) | 2.16647518 |
| 62 | Broad metatarsal (HP:0001783) | 2.15861059 |
| 63 | Bulbar palsy (HP:0001283) | 2.14390232 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.11222620 |
| 65 | Atrioventricular block (HP:0001678) | 2.09060899 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.08415191 |
| 67 | Bladder diverticulum (HP:0000015) | 2.08162919 |
| 68 | Atrophic scars (HP:0001075) | 2.06750030 |
| 69 | Arterial tortuosity (HP:0005116) | 1.99724692 |
| 70 | Hip contracture (HP:0003273) | 1.98457092 |
| 71 | Ventricular arrhythmia (HP:0004308) | 1.94225900 |
| 72 | Areflexia of lower limbs (HP:0002522) | 1.92101540 |
| 73 | Fragile skin (HP:0001030) | 1.91097279 |
| 74 | Rimmed vacuoles (HP:0003805) | 1.90972046 |
| 75 | Generalized muscle weakness (HP:0003324) | 1.90125486 |
| 76 | Bell-shaped thorax (HP:0001591) | 1.88183474 |
| 77 | Limb-girdle muscle weakness (HP:0003325) | 1.87792580 |
| 78 | Gowers sign (HP:0003391) | 1.87317528 |
| 79 | Wormian bones (HP:0002645) | 1.84379491 |
| 80 | Malignant hyperthermia (HP:0002047) | 1.82884001 |
| 81 | Vertebral compression fractures (HP:0002953) | 1.80628081 |
| 82 | Overgrowth (HP:0001548) | 1.80443923 |
| 83 | Fetal akinesia sequence (HP:0001989) | 1.79767669 |
| 84 | Mitral regurgitation (HP:0001653) | 1.79186954 |
| 85 | Aneurysm (HP:0002617) | 1.78198248 |
| 86 | Hypoplasia of the iris (HP:0007676) | 1.77125085 |
| 87 | Achilles tendon contracture (HP:0001771) | 1.76553709 |
| 88 | Limited hip movement (HP:0008800) | 1.75628844 |
| 89 | Generalized amyotrophy (HP:0003700) | 1.75445315 |
| 90 | Absent phalangeal crease (HP:0006109) | 1.73975207 |
| 91 | Muscular dystrophy (HP:0003560) | 1.73359825 |
| 92 | Soft skin (HP:0000977) | 1.72453636 |
| 93 | Waddling gait (HP:0002515) | 1.67643900 |
| 94 | Dilatation of the ascending aorta (HP:0005111) | 1.67619623 |
| 95 | Bradycardia (HP:0001662) | 1.65756629 |
| 96 | Turricephaly (HP:0000262) | 1.65502120 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.64881706 |
| 98 | Stridor (HP:0010307) | 1.64761728 |
| 99 | Syncope (HP:0001279) | 1.64205333 |
| 100 | Distal upper limb amyotrophy (HP:0007149) | 1.64059433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.68688284 |
| 2 | OBSCN | 4.57762383 |
| 3 | PHKG1 | 3.00421036 |
| 4 | PHKG2 | 3.00421036 |
| 5 | RIPK1 | 2.61464577 |
| 6 | DDR2 | 2.58358092 |
| 7 | TRIB3 | 2.37017318 |
| 8 | TESK1 | 2.23819834 |
| 9 | MYLK | 2.01630828 |
| 10 | MARK1 | 1.99245186 |
| 11 | PRKD3 | 1.89992587 |
| 12 | PDGFRA | 1.89891938 |
| 13 | PAK6 | 1.70933415 |
| 14 | PRPF4B | 1.69450225 |
| 15 | LATS2 | 1.68699113 |
| 16 | MAPK12 | 1.67643582 |
| 17 | PIK3CG | 1.61268615 |
| 18 | STK38 | 1.54026912 |
| 19 | KSR2 | 1.46169302 |
| 20 | DMPK | 1.41298062 |
| 21 | NTRK1 | 1.37904945 |
| 22 | ICK | 1.25298473 |
| 23 | MAP3K7 | 1.24924085 |
| 24 | MAP2K3 | 1.24737133 |
| 25 | NTRK3 | 1.22772188 |
| 26 | EEF2K | 1.19628877 |
| 27 | MARK2 | 1.19396857 |
| 28 | LIMK1 | 1.15977952 |
| 29 | NEK9 | 1.14902699 |
| 30 | MOS | 1.13364298 |
| 31 | ROCK1 | 1.11799826 |
| 32 | ARAF | 1.10462629 |
| 33 | MUSK | 1.10389818 |
| 34 | CDC42BPA | 1.07232144 |
| 35 | PDPK1 | 1.05920381 |
| 36 | CAMK2G | 1.05495419 |
| 37 | TGFBR2 | 1.04300975 |
| 38 | PINK1 | 1.02308428 |
| 39 | EPHA4 | 1.01357057 |
| 40 | ERN1 | 0.99096381 |
| 41 | DAPK2 | 0.98049549 |
| 42 | CAMK1 | 0.97504451 |
| 43 | SIK1 | 0.95672257 |
| 44 | UHMK1 | 0.93653385 |
| 45 | MAP3K13 | 0.93563293 |
| 46 | TRPM7 | 0.92001830 |
| 47 | RPS6KA2 | 0.91075016 |
| 48 | ROCK2 | 0.86894879 |
| 49 | MAPK7 | 0.85384881 |
| 50 | PRKD2 | 0.83155187 |
| 51 | PKN1 | 0.82781772 |
| 52 | SGK3 | 0.81022268 |
| 53 | CAMK2B | 0.79666963 |
| 54 | PAK2 | 0.78764948 |
| 55 | EPHB1 | 0.78298957 |
| 56 | PTK2 | 0.77988431 |
| 57 | CAMK2D | 0.75967517 |
| 58 | PRKG2 | 0.73368893 |
| 59 | PDK1 | 0.69178396 |
| 60 | PRKD1 | 0.69033433 |
| 61 | MAP3K6 | 0.68940742 |
| 62 | MAPKAPK3 | 0.67938577 |
| 63 | MTOR | 0.67529368 |
| 64 | CAMK4 | 0.67342321 |
| 65 | MAP3K11 | 0.66619455 |
| 66 | SGK223 | 0.66140439 |
| 67 | SGK494 | 0.66140439 |
| 68 | MAPK4 | 0.65315537 |
| 69 | TIE1 | 0.64993279 |
| 70 | PRKAA2 | 0.64447389 |
| 71 | DAPK3 | 0.63905901 |
| 72 | MAP3K1 | 0.61823754 |
| 73 | PDGFRB | 0.61348325 |
| 74 | WNK1 | 0.60762488 |
| 75 | LMTK2 | 0.60599076 |
| 76 | DYRK1B | 0.59425830 |
| 77 | ABL2 | 0.59363608 |
| 78 | MAP2K1 | 0.58333887 |
| 79 | RPS6KC1 | 0.57229773 |
| 80 | RPS6KL1 | 0.57229773 |
| 81 | PTK2B | 0.56675633 |
| 82 | MAP2K4 | 0.54854051 |
| 83 | NTRK2 | 0.53737678 |
| 84 | TYRO3 | 0.53194887 |
| 85 | PRKCH | 0.53061701 |
| 86 | SGK2 | 0.53027834 |
| 87 | CAMK2A | 0.52549215 |
| 88 | MAPK10 | 0.51988948 |
| 89 | MAP3K3 | 0.51474072 |
| 90 | CAMK1G | 0.51182071 |
| 91 | PRKAA1 | 0.51155990 |
| 92 | GRK5 | 0.51075395 |
| 93 | CDK5 | 0.49731626 |
| 94 | CAMKK1 | 0.49519577 |
| 95 | TAOK2 | 0.48689823 |
| 96 | PRKG1 | 0.47640687 |
| 97 | MAP3K9 | 0.45186166 |
| 98 | EPHB2 | 0.40956978 |
| 99 | RET | 0.40819444 |
| 100 | AKT2 | 0.40679637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.01497652 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.83719725 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.17353618 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11194655 |
| 5 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02628229 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.73195680 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.70942309 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 1.69277084 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62738892 |
| 10 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60602428 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56986596 |
| 12 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.51762441 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.44213290 |
| 14 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43671815 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.41569917 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40480736 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.35671051 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.34232983 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31993554 |
| 20 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.31710218 |
| 21 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30813414 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29319004 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.26443382 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22396555 |
| 25 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.18524347 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17136414 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14504996 |
| 28 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12651797 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12054908 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.11662712 |
| 31 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.10164237 |
| 32 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09489340 |
| 33 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09056905 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07673561 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06828192 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06225119 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06189192 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.04749048 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.04467480 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.02616916 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02511671 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01635339 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01384042 |
| 44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00856432 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 0.99277356 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 0.99264077 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98118220 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.96235619 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94553394 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92892629 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.92840686 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.91760544 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90400799 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89328429 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88568214 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87148535 |
| 57 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87124019 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85890215 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.85177563 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84960164 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83995192 |
| 62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81528820 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80891053 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80162319 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79342818 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.79037296 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79027053 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76389129 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.73927765 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73849477 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73283596 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.69134184 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.68992098 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67539324 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67407139 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65730642 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65290430 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64758522 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63868320 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63544463 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62832961 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.61216495 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60949447 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59642653 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.59529989 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58564175 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56299989 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56269230 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56155877 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55426063 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55184596 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.54531298 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54400873 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54303378 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52938919 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52291865 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51854784 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51609195 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48791708 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48019413 |

